CVS Health Corporation (NYSE:CVS) Shares Acquired by Old North State Wealth Management LLC

Old North State Wealth Management LLC lifted its stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 14.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 94,657 shares of the pharmacy operator's stock after buying an additional 11,937 shares during the quarter. CVS Health makes up about 3.6% of Old North State Wealth Management LLC's investment portfolio, making the stock its 4th largest holding. Old North State Wealth Management LLC's holdings in CVS Health were worth $6,418,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Whitebox Advisors LLC acquired a new position in CVS Health in the fourth quarter worth $249,000. Fairfax Financial Holdings Ltd. Can acquired a new position in CVS Health in the fourth quarter worth $121,742,000. Lazard Asset Management LLC boosted its holdings in CVS Health by 7.3% in the fourth quarter. Lazard Asset Management LLC now owns 4,290,953 shares of the pharmacy operator's stock worth $192,617,000 after purchasing an additional 293,406 shares during the period. Seizert Capital Partners LLC boosted its holdings in CVS Health by 22.8% in the fourth quarter. Seizert Capital Partners LLC now owns 569,527 shares of the pharmacy operator's stock worth $25,566,000 after purchasing an additional 105,708 shares during the period. Finally, Capital World Investors boosted its holdings in CVS Health by 26.6% in the fourth quarter. Capital World Investors now owns 61,039,777 shares of the pharmacy operator's stock worth $2,739,927,000 after purchasing an additional 12,819,148 shares during the period. Institutional investors and hedge funds own 80.66% of the company's stock.

CVS Health Price Performance

Shares of CVS Health stock opened at $68.13 on Friday. The company's 50-day moving average price is $64.83 and its two-hundred day moving average price is $60.70. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The stock has a market cap of $86.18 billion, a PE ratio of 16.26, a price-to-earnings-growth ratio of 0.95 and a beta of 0.56. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.63. The firm had revenue of $94.59 billion for the quarter, compared to the consensus estimate of $93.07 billion. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The business's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.31 EPS. As a group, sell-side analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Guy P. Sansone bought 1,570 shares of the stock in a transaction on Thursday, June 5th. The shares were bought at an average price of $63.70 per share, with a total value of $100,009.00. Following the purchase, the director now directly owns 12,007 shares in the company, valued at $764,845.90. The trade was a 15.04% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 1.22% of the company's stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the stock. Wall Street Zen raised shares of CVS Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Morgan Stanley reissued an "overweight" rating on shares of CVS Health in a report on Tuesday, April 15th. UBS Group boosted their price target on shares of CVS Health from $67.00 to $71.00 and gave the company a "neutral" rating in a report on Friday, May 2nd. Wells Fargo & Company reissued an "overweight" rating and set a $84.00 price target (up previously from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Finally, Cowen reissued a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Two research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, CVS Health currently has an average rating of "Moderate Buy" and an average target price of $74.75.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.